Related Experiment Videos
[Gentamycin sulfate in the therapy of acute and chronic pneumonias]
Abstract:
Clinical efficacy of gentamicin in treatment of acute and chronic pneumonia was shown. The wide antibacterial spectrum of the antibiotic provided its use in therapy of mixed bacterial infections. Satisfactory results were observed in 47 (93.7 per cent) out of 51 patients. The adverse reactions, such as proteinuria, hematuria, and polymorphous eruption were recorded in 5 patients and vanished after discontinuation of the drug. On the basis of the experience acquired the drug may be recommended for use in pulmonology.
Insights
Gentamicin effectively treated pneumonia in 93.7% of patients with mixed bacterial infections. While some adverse reactions occurred, they were transient, supporting gentamicin
Area of Science:
- Pulmonology
- Infectious Diseases
- Pharmacology
Background:
- Pneumonia, a significant respiratory illness, often involves mixed bacterial infections.
- Antibiotic selection is crucial for effective pneumonia treatment, especially in complex cases.
Purpose of the Study:
- To evaluate the clinical efficacy of gentamicin in treating acute and chronic pneumonia.
- To assess the safety and tolerability of gentamicin in pulmonary infections.
Main Methods:
- Clinical trial involving 51 patients with acute and chronic pneumonia.
- Treatment with gentamicin for mixed bacterial infections.
- Monitoring of treatment outcomes and adverse reactions.
Main Results:
- Satisfactory clinical efficacy observed in 47 out of 51 patients (93.7%).
- Gentamicin demonstrated effectiveness against mixed bacterial infections due to its broad antibacterial spectrum.
- Adverse reactions (proteinuria, hematuria, rash) occurred in 5 patients but resolved after drug discontinuation.
Conclusions:
- Gentamicin is a recommended therapeutic option for pneumonia, particularly in cases of mixed bacterial etiology.
- The drug exhibits a favorable efficacy and safety profile for pulmonology applications.
- Further research may explore gentamicin's role in specific pneumonia subtypes.